All lobbying filings

THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $80,000.00 expenses · posted Oct 20, 2025

Official filing document

Bills named in this filing 5

S 1784
MAPS Act
HR 4191
MAPS Act
HR 5304
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2587
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026
S 2296
National Defense Authorization Act for Fiscal Year 2026

Lobbying activity 3

Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.

Budget/Appropriations

H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Defense

S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.